CONFIDENTIAL TREATMENT FOR MARKED PORTIONS REQUESTED UNDER 17 C.F.R. SECTION 200.80(b)(4) and 240.24(b).*Revolving Credit Facility Agreement • September 11th, 1997 • Somatogen Inc • Biological products, (no disgnostic substances) • Indiana
RECITALForm of Retention Agreement • September 11th, 1997 • Somatogen Inc • Biological products, (no disgnostic substances) • Colorado
AMENDMENT DATED JULY 23, 1997 TO EXCLUSIVE AGENCY AGREEMENT WITH BINSWANGER CHESTERTON. July 23, 1997 The Binswanger Companies Two Logan Square, 4th Floor 18th and Arch Streets Philadelphia, PA 19103-2759 Re: Boulder, Colorado Ladies and Gentlemen:...Exclusive Agency Agreement • September 11th, 1997 • Somatogen Inc • Biological products, (no disgnostic substances)
